Literature DB >> 16954001

Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.

Christopher C Butler1, Sharon Hillier, Zoë Roberts, Frank Dunstan, Anthony Howard, Stephen Palmer.   

Abstract

BACKGROUND: Antimicrobial resistance is considered to be one of the major threats to public health. However, the practical implications for patients and workload in primary care are largely unknown. AIM: To determine outcomes for patients managed in primary care with an antibiotic resistant compared to an antibiotic sensitive Escherichia coli (E. coli) urinary tract infection (UTI).
DESIGN: Nested case control study with prospective measurement of outcomes.
SETTING: Ten general practices in South Wales.
METHOD: Patients consulting with symptoms suggestive of UTI identified through systematic sampling, and with a laboratory proven E. coli infection, were followed up by interview 1 month after their consultations and by searching of their medical records.
RESULTS: Nine hundred and thirty-two patients were interviewed and had their medical records reviewed. The risk of patients reporting 'feeling poorly', 'frequency or pain on urinating' and being 'out of action' for more than 5 days after consulting was significantly increased for patients with resistant compared to sensitive infections. After adjusting for risk factors, there was an increased risk of 'frequency or pain on urinating' and 'being out of action' for those infected with a resistant E. coli. The median number of maximum reported days with at least one symptom was 12 days for patients with E. coli infections resistant to trimethoprim, 7 days for infections resistant to ampicillin, 7 days for infections resistant to any antibiotic, and 5 days for infections sensitive to all tested antibiotics. Even if treated with an appropriate antibiotic, infections caused by a resistant strain were symptomatic for longer. For those infected with an organism resistant to at least one antibiotic, the odds ratio (OR) for re-visiting their GP within the next 30 days for the UTI was 1.47 (95% confidence interval [CI] = 1.10 to 1.95). The OR was 1.49 (95% CI = 1.11 to 2.00) for ampicillin resistance and 2.48 (95% CI = 1.70 to 3.59) for trimethoprim resistance.
CONCLUSIONS: Resistant E. coli UTIs are symptomatic for longer and cause increased work load in general practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954001      PMCID: PMC1876635     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  14 in total

1.  Factors associated with trimethoprim-resistant bacteria isolated from urine samples.

Authors:  D T Steinke; R A Seaton; G Phillips; T M MacDonald; P G Davey
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

2.  Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.

Authors:  Thomas M Hooton; Delia Scholes; Kalpana Gupta; Ann E Stapleton; Pacita L Roberts; Walter E Stamm
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

3.  Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates.

Authors:  S W Wright; K D Wrenn; M L Haynes
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

4.  Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection.

Authors:  L E Nicolle; A I Hoepelman; M Floor; J Verhoef; K Norgard
Journal:  Scand J Infect Dis       Date:  1993

5.  Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

Authors:  R Raz; B Chazan; Y Kennes; R Colodner; E Rottensterich; M Dan; I Lavi; W Stamm
Journal:  Clin Infect Dis       Date:  2002-04-04       Impact factor: 9.079

6.  Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats.

Authors:  C C Butler; S Rollnick; R Pill; F Maggs-Rapport; N Stott
Journal:  BMJ       Date:  1998-09-05

7.  Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study.

Authors:  S Einarsson; M Kristjansson; K G Kristinsson; G Kjartansson; S Jonsson
Journal:  Scand J Infect Dis       Date:  1998

Review 8.  Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI.

Authors:  Kalpana Gupta; Walter E Stamm
Journal:  Int J Antimicrob Agents       Date:  2002-06       Impact factor: 5.283

9.  High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women.

Authors:  R G Masterton; J A Bochsler
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

Review 10.  Resistance trends in urinary tract pathogens and impact on management.

Authors:  Tony Mazzulli
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  51 in total

1.  'The body gets used to them': patients' interpretations of antibiotic resistance and the implications for containment strategies.

Authors:  Lucy Brookes-Howell; Glyn Elwyn; Kerenza Hood; Fiona Wood; Lucy Cooper; Herman Goossens; Margareta Ieven; Christopher C Butler
Journal:  J Gen Intern Med       Date:  2011-11-08       Impact factor: 5.128

2.  Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices.

Authors:  Chris C Butler; Frank Dunstan; Margaret Heginbothom; Brendan Mason; Zoë Roberts; Sharon Hillier; Robin Howe; Stephen Palmer; Anthony Howard
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

3.  Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study.

Authors:  P Little; R Merriman; S Turner; K Rumsby; G Warner; J A Lowes; H Smith; C Hawke; G Leydon; M Mullee; M V Moore
Journal:  BMJ       Date:  2010-02-05

Review 4.  Chinese herbal medicine for treating recurrent urinary tract infections in women.

Authors:  Andrew Flower; Li-Qiong Wang; George Lewith; Jian Ping Liu; Qing Li
Journal:  Cochrane Database Syst Rev       Date:  2015-06-04

5.  Improving the appropriateness of antimicrobial use in primary care after implementation of a local antimicrobial guide in both levels of care.

Authors:  Rocío Fernández Urrusuno; Macarena Flores Dorado; Angel Vilches Arenas; Carmen Serrano Martino; Susana Corral Baena; Ma Carmen Montero Balosa
Journal:  Eur J Clin Pharmacol       Date:  2014-06-03       Impact factor: 2.953

6.  Clinical relevance of bacterial resistance in lower respiratory tract infection in primary care: secondary analysis of a multicentre European trial.

Authors:  Jolien Teepe; Berna Dl Broekhuizen; Herman Goossens; Patricia Marinka Hordijk; Katherine Loens; Christine Lammens; Margareta Ieven; Paul Little; Chris C Butler; Samuel Coenen; Maciek Godycki-Cwirko; Birgitta Henriques-Normark; Theo Jm Verheij
Journal:  Br J Gen Pract       Date:  2018-07-30       Impact factor: 5.386

7.  Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis.

Authors:  Mary A Duffy; Virginia Hernandez-Santiago; Gillian Orange; Peter G Davey; Bruce Guthrie
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

8.  Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.

Authors:  Gilho Lee; Yong-Hyun Cho; Bong Suk Shim; Sang Don Lee
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

9.  Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial.

Authors:  Nick A Francis; Christopher C Butler; Kerenza Hood; Sharon Simpson; Fiona Wood; Jacqueline Nuttall
Journal:  BMJ       Date:  2009-07-29

10.  Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use.

Authors:  Alma Brolund; Martin Sundqvist; Gunnar Kahlmeter; Malin Grape
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.